

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 9.14468802 |
| 2 | negative thymic T cell selection (GO:0045060) | 9.07902841 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 8.78869616 |
| 4 | positive thymic T cell selection (GO:0045059) | 8.58214387 |
| 5 | T cell migration (GO:0072678) | 8.11019105 |
| 6 | leukocyte aggregation (GO:0070486) | 8.08478507 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.94898612 |
| 8 | positive T cell selection (GO:0043368) | 7.57473922 |
| 9 | thymic T cell selection (GO:0045061) | 7.21528961 |
| 10 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 7.19895877 |
| 11 | regulation of gamma-delta T cell differentiation (GO:0045586) | 7.10282027 |
| 12 | sequestering of actin monomers (GO:0042989) | 6.68155278 |
| 13 | T cell selection (GO:0045058) | 6.48366874 |
| 14 | negative regulation of T cell mediated immunity (GO:0002710) | 6.41854629 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 6.26706062 |
| 16 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 6.23066203 |
| 17 | cellular response to interleukin-15 (GO:0071350) | 6.21301983 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.07568123 |
| 19 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.07568123 |
| 20 | interferon-gamma production (GO:0032609) | 6.00788212 |
| 21 | regulation of isotype switching to IgG isotypes (GO:0048302) | 5.97366406 |
| 22 | negative regulation of cell killing (GO:0031342) | 5.96585527 |
| 23 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.96585527 |
| 24 | response to interleukin-15 (GO:0070672) | 5.88883280 |
| 25 | T cell costimulation (GO:0031295) | 5.74127177 |
| 26 | T cell receptor signaling pathway (GO:0050852) | 5.69884231 |
| 27 | lymphocyte costimulation (GO:0031294) | 5.62993333 |
| 28 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 5.40989524 |
| 29 | interleukin-6-mediated signaling pathway (GO:0070102) | 5.36691152 |
| 30 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 5.34849638 |
| 31 | alpha-beta T cell activation (GO:0046631) | 5.20916537 |
| 32 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 5.13530612 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.97111777 |
| 34 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.95458164 |
| 35 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.93096613 |
| 36 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.91214453 |
| 37 | daunorubicin metabolic process (GO:0044597) | 4.85035127 |
| 38 | polyketide metabolic process (GO:0030638) | 4.85035127 |
| 39 | doxorubicin metabolic process (GO:0044598) | 4.85035127 |
| 40 | regulation of T cell tolerance induction (GO:0002664) | 4.74358574 |
| 41 | T-helper cell differentiation (GO:0042093) | 4.68713120 |
| 42 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 4.68713120 |
| 43 | Peyers patch development (GO:0048541) | 4.65850157 |
| 44 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.65850157 |
| 45 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.65476246 |
| 46 | positive regulation of T-helper 1 type immune response (GO:0002827) | 4.64968266 |
| 47 | positive regulation of T cell cytokine production (GO:0002726) | 4.63624764 |
| 48 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.61582199 |
| 49 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.55638971 |
| 50 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.54512935 |
| 51 | positive regulation of interleukin-2 production (GO:0032743) | 4.42200485 |
| 52 | cellular response to interleukin-4 (GO:0071353) | 4.39719593 |
| 53 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.37558945 |
| 54 | lymphocyte migration (GO:0072676) | 4.29887742 |
| 55 | regulation of regulatory T cell differentiation (GO:0045589) | 4.29305616 |
| 56 | positive regulation of T cell chemotaxis (GO:0010820) | 4.27180209 |
| 57 | regulation of T cell chemotaxis (GO:0010819) | 4.27180209 |
| 58 | positive regulation of transforming growth factor beta production (GO:0071636) | 4.27042815 |
| 59 | histone H3-K4 trimethylation (GO:0080182) | 4.21883627 |
| 60 | T cell differentiation involved in immune response (GO:0002292) | 4.14457558 |
| 61 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 4.14457558 |
| 62 | alpha-beta T cell activation involved in immune response (GO:0002287) | 4.14457558 |
| 63 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.12149249 |
| 64 | regulation of immunoglobulin secretion (GO:0051023) | 4.11752689 |
| 65 | B cell proliferation (GO:0042100) | 3.96299027 |
| 66 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.91829724 |
| 67 | positive regulation of type 2 immune response (GO:0002830) | 3.89669780 |
| 68 | positive regulation of humoral immune response (GO:0002922) | 3.88471553 |
| 69 | tolerance induction (GO:0002507) | 3.87596444 |
| 70 | activated T cell proliferation (GO:0050798) | 3.83576033 |
| 71 | regulation of T cell cytokine production (GO:0002724) | 3.82900795 |
| 72 | positive regulation of tolerance induction (GO:0002645) | 3.82148149 |
| 73 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.79273300 |
| 74 | response to interleukin-4 (GO:0070670) | 3.79016627 |
| 75 | regulation of T-helper 1 type immune response (GO:0002825) | 3.74427934 |
| 76 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.73930298 |
| 77 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.73559602 |
| 78 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.72477007 |
| 79 | natural killer cell differentiation (GO:0001779) | 3.71793248 |
| 80 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.70175254 |
| 81 | positive regulation of B cell mediated immunity (GO:0002714) | 3.70175254 |
| 82 | T cell differentiation (GO:0030217) | 3.69846791 |
| 83 | NIK/NF-kappaB signaling (GO:0038061) | 3.67324124 |
| 84 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.63310701 |
| 85 | mast cell activation (GO:0045576) | 3.62783065 |
| 86 | lymph node development (GO:0048535) | 3.61531667 |
| 87 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.59930943 |
| 88 | positive regulation of neutrophil chemotaxis (GO:0090023) | 3.59315524 |
| 89 | positive regulation of neutrophil migration (GO:1902624) | 3.59315524 |
| 90 | positive regulation of lamellipodium assembly (GO:0010592) | 3.58445620 |
| 91 | negative regulation of interleukin-2 production (GO:0032703) | 3.55628487 |
| 92 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.55294649 |
| 93 | negative regulation of B cell mediated immunity (GO:0002713) | 3.55174016 |
| 94 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.55174016 |
| 95 | T cell proliferation (GO:0042098) | 3.51826769 |
| 96 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 3.51317937 |
| 97 | regulation of immunoglobulin production (GO:0002637) | 3.49102434 |
| 98 | regulation of respiratory burst (GO:0060263) | 3.48717306 |
| 99 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.48149629 |
| 100 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.46774376 |
| 101 | positive regulation of immunoglobulin production (GO:0002639) | 3.43248465 |
| 102 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.42958955 |
| 103 | termination of RNA polymerase III transcription (GO:0006386) | 3.42958955 |
| 104 | leukocyte cell-cell adhesion (GO:0007159) | 3.42317134 |
| 105 | positive regulation of cell killing (GO:0031343) | 3.42101294 |
| 106 | regulation of B cell differentiation (GO:0045577) | 3.40317676 |
| 107 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 3.39832291 |
| 108 | positive regulation of astrocyte differentiation (GO:0048711) | 3.38428735 |
| 109 | positive regulation of isotype switching (GO:0045830) | 3.38078825 |
| 110 | negative regulation of alpha-beta T cell activation (GO:0046636) | 3.38071034 |
| 111 | positive regulation of macrophage differentiation (GO:0045651) | 3.37332595 |
| 112 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 3.33501542 |
| 113 | regulation of response to interferon-gamma (GO:0060330) | 3.31741983 |
| 114 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.31135562 |
| 115 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29984750 |
| 116 | regulation of defense response to virus by virus (GO:0050690) | 3.29631218 |
| 117 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.28792441 |
| 118 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 3.28783529 |
| 119 | regulation of tolerance induction (GO:0002643) | 3.27122550 |
| 120 | regulation of isotype switching (GO:0045191) | 3.25419407 |
| 121 | positive regulation of T cell activation (GO:0050870) | 3.25092127 |
| 122 | negative regulation of adaptive immune response (GO:0002820) | 3.24112359 |
| 123 | regulation of cell killing (GO:0031341) | 3.22837350 |
| 124 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.22761583 |
| 125 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.22614955 |
| 126 | regulation of interleukin-2 production (GO:0032663) | 3.22499635 |
| 127 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.22365562 |
| 128 | regulation of interleukin-4 production (GO:0032673) | 3.21937571 |
| 129 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.19994103 |
| 130 | natural killer cell activation (GO:0030101) | 3.19283082 |
| 131 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 3.19205500 |
| 132 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.19044591 |
| 133 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.19044591 |
| 134 | positive regulation of granulocyte differentiation (GO:0030854) | 3.18152365 |
| 135 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.17157219 |
| 136 | positive regulation of granulocyte chemotaxis (GO:0071624) | 3.16423452 |
| 137 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.15865753 |
| 138 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.15865753 |
| 139 | DNA deamination (GO:0045006) | 3.15190350 |
| 140 | T cell homeostasis (GO:0043029) | 3.13545396 |
| 141 | positive regulation of T cell mediated immunity (GO:0002711) | 3.12821985 |
| 142 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.10351930 |
| 143 | regulation of B cell mediated immunity (GO:0002712) | 3.10063973 |
| 144 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.09779577 |
| 145 | T cell activation (GO:0042110) | 3.09336608 |
| 146 | lymphocyte chemotaxis (GO:0048247) | 3.09217597 |
| 147 | alpha-beta T cell differentiation (GO:0046632) | 3.09081042 |
| 148 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.04606299 |
| 149 | regulation of alpha-beta T cell activation (GO:0046634) | 3.03757956 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.61819484 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.26468480 |
| 3 | RUNX_20019798_ChIP-Seq_JUKART_Human | 4.19078744 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.09979270 |
| 5 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.93495800 |
| 6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.71878330 |
| 7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.68177733 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.65870286 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.45573813 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 3.44051222 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.37523573 |
| 12 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.27938097 |
| 13 | UTX_26944678_Chip-Seq_JUKART_Human | 3.18554535 |
| 14 | MAF_26560356_Chip-Seq_TH1_Human | 2.96051259 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.86635989 |
| 16 | VDR_22108803_ChIP-Seq_LS180_Human | 2.79165307 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.72751612 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.71960227 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.66756924 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.59573569 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.53100882 |
| 22 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47499803 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.30991722 |
| 24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.22950133 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 2.17714263 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.16879065 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.12815248 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.09046238 |
| 29 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.08880140 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02373095 |
| 31 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.99437570 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.95091388 |
| 33 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.93393206 |
| 34 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88618171 |
| 35 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86965596 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.86841759 |
| 37 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.86229720 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86117461 |
| 39 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85572967 |
| 40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.84900505 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79863700 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77914196 |
| 43 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.74458634 |
| 44 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73177810 |
| 45 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.70677790 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68567730 |
| 47 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.66231493 |
| 48 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.63716170 |
| 49 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.62700130 |
| 50 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61097150 |
| 51 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58181178 |
| 52 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.52566319 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.49690978 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46419342 |
| 55 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.45524366 |
| 56 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.43302269 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40880568 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.38420138 |
| 59 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.38381243 |
| 60 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34837834 |
| 61 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.34517284 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34097291 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31937864 |
| 64 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29097674 |
| 65 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.28296289 |
| 66 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.27989663 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27665840 |
| 68 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26182994 |
| 69 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23984193 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22495237 |
| 71 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.22475885 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22317484 |
| 73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22301693 |
| 74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.21381129 |
| 75 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20966172 |
| 76 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.19647087 |
| 77 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19349818 |
| 78 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.18342888 |
| 79 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.14672448 |
| 80 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13631274 |
| 81 | GATA3_26560356_Chip-Seq_TH1_Human | 1.12531328 |
| 82 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.11502890 |
| 83 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05743936 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05685130 |
| 85 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02289033 |
| 86 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01130757 |
| 87 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00750299 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.00690053 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99041151 |
| 90 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.98721232 |
| 91 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.98485366 |
| 92 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.97994344 |
| 93 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.97000985 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95082089 |
| 95 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.94833337 |
| 96 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.94165056 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.93211313 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92638851 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 0.91944857 |
| 100 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91847947 |
| 101 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91663357 |
| 102 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.91180595 |
| 103 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90902931 |
| 104 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90420358 |
| 105 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.90408914 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.86825660 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84214603 |
| 108 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.83863788 |
| 109 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83708010 |
| 110 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83260129 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83183698 |
| 112 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82892540 |
| 113 | GATA3_26560356_Chip-Seq_TH2_Human | 0.82527962 |
| 114 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.82087474 |
| 115 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.81850601 |
| 116 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81010700 |
| 117 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.80988967 |
| 118 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80689513 |
| 119 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.79107042 |
| 120 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.77849499 |
| 121 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76584887 |
| 122 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.75715025 |
| 123 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.75596472 |
| 124 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.75559684 |
| 125 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74406332 |
| 126 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.73564752 |
| 127 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.73057295 |
| 128 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.72447159 |
| 129 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.72333296 |
| 130 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72084545 |
| 131 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.71677769 |
| 132 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.70963122 |
| 133 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.70485286 |
| 134 | GATA1_22025678_ChIP-Seq_K562_Human | 0.70214010 |
| 135 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.69593287 |
| 136 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.68998397 |
| 137 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.68433697 |
| 138 | P300_27268052_Chip-Seq_Bcells_Human | 0.68424707 |
| 139 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.68050174 |
| 140 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68043063 |
| 141 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.67454511 |
| 142 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.66954333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 6.77521010 |
| 2 | MP0005671_abnormal_response_to | 5.17850345 |
| 3 | MP0003724_increased_susceptibility_to | 3.70266925 |
| 4 | MP0000685_abnormal_immune_system | 3.62606102 |
| 5 | MP0009785_altered_susceptibility_to | 3.58776472 |
| 6 | MP0002933_joint_inflammation | 3.27358801 |
| 7 | MP0008877_abnormal_DNA_methylation | 3.24476337 |
| 8 | MP0006082_CNS_inflammation | 3.04671222 |
| 9 | MP0003436_decreased_susceptibility_to | 3.02960801 |
| 10 | MP0004381_abnormal_hair_follicle | 2.90620311 |
| 11 | MP0009333_abnormal_splenocyte_physiolog | 2.87731682 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.79803812 |
| 13 | MP0002420_abnormal_adaptive_immunity | 2.78411383 |
| 14 | MP0002405_respiratory_system_inflammati | 2.72972475 |
| 15 | MP0000703_abnormal_thymus_morphology | 2.72667845 |
| 16 | MP0001819_abnormal_immune_cell | 2.72567746 |
| 17 | MP0001800_abnormal_humoral_immune | 2.69918424 |
| 18 | MP0002398_abnormal_bone_marrow | 2.69200529 |
| 19 | MP0002723_abnormal_immune_serum | 2.65788149 |
| 20 | MP0005025_abnormal_response_to | 2.57390814 |
| 21 | MP0001835_abnormal_antigen_presentation | 2.43136192 |
| 22 | MP0003646_muscle_fatigue | 2.39257524 |
| 23 | MP0001790_abnormal_immune_system | 2.37016092 |
| 24 | MP0005387_immune_system_phenotype | 2.37016092 |
| 25 | MP0000716_abnormal_immune_system | 2.33890965 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 2.33754751 |
| 27 | MP0002166_altered_tumor_susceptibility | 2.31247422 |
| 28 | MP0002452_abnormal_antigen_presenting | 2.28416962 |
| 29 | MP0003866_abnormal_defecation | 2.19745468 |
| 30 | MP0002722_abnormal_immune_system | 2.17538593 |
| 31 | MP0003045_fibrosis | 2.14927671 |
| 32 | MP0000689_abnormal_spleen_morphology | 2.10310579 |
| 33 | MP0001873_stomach_inflammation | 1.90888046 |
| 34 | MP0002396_abnormal_hematopoietic_system | 1.90333312 |
| 35 | MP0005083_abnormal_biliary_tract | 1.84188450 |
| 36 | MP0002429_abnormal_blood_cell | 1.83358349 |
| 37 | MP0003172_abnormal_lysosome_physiology | 1.81014680 |
| 38 | MP0004510_myositis | 1.80822299 |
| 39 | MP0002006_tumorigenesis | 1.75048468 |
| 40 | MP0010155_abnormal_intestine_physiology | 1.71310877 |
| 41 | MP0002419_abnormal_innate_immunity | 1.62729443 |
| 42 | MP0004947_skin_inflammation | 1.60556865 |
| 43 | MP0003300_gastrointestinal_ulcer | 1.58723164 |
| 44 | MP0000613_abnormal_salivary_gland | 1.55588795 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.50158190 |
| 46 | MP0005451_abnormal_body_composition | 1.43994722 |
| 47 | MP0001243_abnormal_dermal_layer | 1.43719876 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.39776725 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.36230813 |
| 50 | MP0000604_amyloidosis | 1.34839043 |
| 51 | MP0004142_abnormal_muscle_tone | 1.33484575 |
| 52 | MP0005075_abnormal_melanosome_morpholog | 1.26511985 |
| 53 | MP0003303_peritoneal_inflammation | 1.25999012 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.22970255 |
| 55 | MP0003329_amyloid_beta_deposits | 1.21410946 |
| 56 | MP0003448_altered_tumor_morphology | 1.20517105 |
| 57 | MP0008469_abnormal_protein_level | 1.18998987 |
| 58 | MP0008872_abnormal_physiological_respon | 1.17791515 |
| 59 | MP0009384_cardiac_valve_regurgitation | 1.16955554 |
| 60 | MP0000465_gastrointestinal_hemorrhage | 1.16661761 |
| 61 | MP0005076_abnormal_cell_differentiation | 1.15054831 |
| 62 | MP0001853_heart_inflammation | 1.12323460 |
| 63 | MP0009840_abnormal_foam_cell | 1.09966732 |
| 64 | MP0005310_abnormal_salivary_gland | 1.09778653 |
| 65 | MP0002277_abnormal_respiratory_mucosa | 1.08525324 |
| 66 | MP0002019_abnormal_tumor_incidence | 1.08364136 |
| 67 | MP0000490_abnormal_crypts_of | 1.04055539 |
| 68 | MP0004808_abnormal_hematopoietic_stem | 0.99717872 |
| 69 | MP0001501_abnormal_sleep_pattern | 0.99604200 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 0.99184555 |
| 71 | MP0004742_abnormal_vestibular_system | 0.97712933 |
| 72 | MP0003221_abnormal_cardiomyocyte_apopto | 0.95720556 |
| 73 | MP0001764_abnormal_homeostasis | 0.92481770 |
| 74 | MP0009765_abnormal_xenobiotic_induced | 0.89096904 |
| 75 | MP0002132_abnormal_respiratory_system | 0.88921265 |
| 76 | MP0001851_eye_inflammation | 0.86719558 |
| 77 | MP0005023_abnormal_wound_healing | 0.86434973 |
| 78 | MP0005085_abnormal_gallbladder_physiolo | 0.86089234 |
| 79 | MP0005379_endocrine/exocrine_gland_phen | 0.85574810 |
| 80 | MP0000372_irregular_coat_pigmentation | 0.85544169 |
| 81 | MP0001663_abnormal_digestive_system | 0.84260780 |
| 82 | MP0009763_increased_sensitivity_to | 0.81094189 |
| 83 | MP0008007_abnormal_cellular_replicative | 0.79515778 |
| 84 | MP0004233_abnormal_muscle_weight | 0.77674471 |
| 85 | MP0000343_altered_response_to | 0.76720293 |
| 86 | MP0001346_abnormal_lacrimal_gland | 0.76137800 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.75513321 |
| 88 | MP0002163_abnormal_gland_morphology | 0.75495467 |
| 89 | MP0000858_altered_metastatic_potential | 0.75059864 |
| 90 | MP0001661_extended_life_span | 0.74259632 |
| 91 | MP0004957_abnormal_blastocyst_morpholog | 0.72829649 |
| 92 | MP0000920_abnormal_myelination | 0.72088667 |
| 93 | MP0009764_decreased_sensitivity_to | 0.67289196 |
| 94 | MP0002009_preneoplasia | 0.65008547 |
| 95 | MP0000609_abnormal_liver_physiology | 0.64910849 |
| 96 | MP0005166_decreased_susceptibility_to | 0.64305701 |
| 97 | MP0003077_abnormal_cell_cycle | 0.62919606 |
| 98 | MP0001545_abnormal_hematopoietic_system | 0.62416424 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 0.62416424 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.61374856 |
| 101 | MP0008875_abnormal_xenobiotic_pharmacok | 0.60908607 |
| 102 | MP0006035_abnormal_mitochondrial_morpho | 0.60784234 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.59744840 |
| 104 | MP0008057_abnormal_DNA_replication | 0.56955357 |
| 105 | MP0002998_abnormal_bone_remodeling | 0.56456311 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 0.54480334 |
| 107 | MP0000477_abnormal_intestine_morphology | 0.54478646 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.54349922 |
| 109 | MP0008569_lethality_at_weaning | 0.50335726 |
| 110 | MP0003878_abnormal_ear_physiology | 0.49161132 |
| 111 | MP0005377_hearing/vestibular/ear_phenot | 0.49161132 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.45228425 |
| 113 | MP0002168_other_aberrant_phenotype | 0.44411575 |
| 114 | MP0001270_distended_abdomen | 0.44175352 |
| 115 | MP0003011_delayed_dark_adaptation | 0.43572165 |
| 116 | MP0003795_abnormal_bone_structure | 0.43441951 |
| 117 | MP0000750_abnormal_muscle_regeneration | 0.42552792 |
| 118 | MP0002083_premature_death | 0.42356351 |
| 119 | MP0001919_abnormal_reproductive_system | 0.41140941 |
| 120 | MP0003943_abnormal_hepatobiliary_system | 0.40108000 |
| 121 | MP0005330_cardiomyopathy | 0.39837365 |
| 122 | MP0001216_abnormal_epidermal_layer | 0.39611782 |
| 123 | MP0005390_skeleton_phenotype | 0.38819766 |
| 124 | MP0005381_digestive/alimentary_phenotyp | 0.38755583 |
| 125 | MP0002970_abnormal_white_adipose | 0.37547791 |
| 126 | MP0003806_abnormal_nucleotide_metabolis | 0.37046035 |
| 127 | MP0003959_abnormal_lean_body | 0.36844493 |
| 128 | MP0003633_abnormal_nervous_system | 0.36397170 |
| 129 | MP0002822_catalepsy | 0.35519001 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.35352417 |
| 131 | MP0000249_abnormal_blood_vessel | 0.34150619 |
| 132 | MP0004145_abnormal_muscle_electrophysio | 0.34000352 |
| 133 | MP0003693_abnormal_embryo_hatching | 0.33979359 |
| 134 | MP0003567_abnormal_fetal_cardiomyocyte | 0.32412647 |
| 135 | MP0008873_increased_physiological_sensi | 0.32267317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Severe combined immunodeficiency (HP:0004430) | 8.36192212 |
| 2 | T lymphocytopenia (HP:0005403) | 7.26945414 |
| 3 | Combined immunodeficiency (HP:0005387) | 7.26765573 |
| 4 | Optic neuritis (HP:0100653) | 7.18775965 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 7.18775965 |
| 6 | Stomatitis (HP:0010280) | 7.07785849 |
| 7 | Abnormality of T cell number (HP:0011839) | 7.05785476 |
| 8 | Orchitis (HP:0100796) | 6.63413444 |
| 9 | Myositis (HP:0100614) | 6.62819291 |
| 10 | Panhypogammaglobulinemia (HP:0003139) | 6.02228537 |
| 11 | Eczematoid dermatitis (HP:0000976) | 5.99856682 |
| 12 | Recurrent fungal infections (HP:0002841) | 5.26549496 |
| 13 | Abnormality of T cells (HP:0002843) | 5.20691369 |
| 14 | Recurrent bronchitis (HP:0002837) | 5.13294840 |
| 15 | IgG deficiency (HP:0004315) | 5.10367033 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 5.00751830 |
| 17 | Keratoconjunctivitis (HP:0001096) | 4.59151591 |
| 18 | Chronic diarrhea (HP:0002028) | 4.51443712 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 4.39682976 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 4.39682976 |
| 21 | Abnormality of eosinophils (HP:0001879) | 4.18454572 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.07171428 |
| 23 | Hypoplasia of the thymus (HP:0000778) | 3.99013142 |
| 24 | Chronic otitis media (HP:0000389) | 3.95994612 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.90488988 |
| 26 | Encephalitis (HP:0002383) | 3.87916119 |
| 27 | Microvesicular hepatic steatosis (HP:0001414) | 3.83791310 |
| 28 | IgM deficiency (HP:0002850) | 3.82605894 |
| 29 | Mitral stenosis (HP:0001718) | 3.77215038 |
| 30 | Recurrent viral infections (HP:0004429) | 3.75297648 |
| 31 | Leukocytosis (HP:0001974) | 3.75195049 |
| 32 | Thyroiditis (HP:0100646) | 3.69298434 |
| 33 | Nasal polyposis (HP:0100582) | 3.66009063 |
| 34 | Eosinophilia (HP:0001880) | 3.64106932 |
| 35 | Increased IgM level (HP:0003496) | 3.60702564 |
| 36 | Abnormality of T cell physiology (HP:0011840) | 3.44733853 |
| 37 | Joint swelling (HP:0001386) | 3.40477112 |
| 38 | Gastrointestinal infarctions (HP:0005244) | 3.40401250 |
| 39 | Lymphopenia (HP:0001888) | 3.36629941 |
| 40 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.24578874 |
| 41 | B lymphocytopenia (HP:0010976) | 3.24005811 |
| 42 | Abnormality of B cell number (HP:0010975) | 3.24005811 |
| 43 | Gangrene (HP:0100758) | 3.11441917 |
| 44 | IgA deficiency (HP:0002720) | 3.09428107 |
| 45 | Pustule (HP:0200039) | 3.04077000 |
| 46 | Abnormality of the nasal mucosa (HP:0000433) | 3.04044729 |
| 47 | Type I transferrin isoform profile (HP:0003642) | 3.02898919 |
| 48 | Granulocytopenia (HP:0001913) | 2.97793506 |
| 49 | 3-Methylglutaconic aciduria (HP:0003535) | 2.91345799 |
| 50 | Anorexia (HP:0002039) | 2.90772850 |
| 51 | Hypoproteinemia (HP:0003075) | 2.77422567 |
| 52 | Bronchitis (HP:0012387) | 2.76710704 |
| 53 | Abnormality of alanine metabolism (HP:0010916) | 2.74197403 |
| 54 | Hyperalaninemia (HP:0003348) | 2.74197403 |
| 55 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.74197403 |
| 56 | Round ear (HP:0100830) | 2.74115557 |
| 57 | Arterial thrombosis (HP:0004420) | 2.71226607 |
| 58 | Mutism (HP:0002300) | 2.70812552 |
| 59 | Pulmonary embolism (HP:0002204) | 2.67922234 |
| 60 | Increased IgE level (HP:0003212) | 2.66724628 |
| 61 | Wrist flexion contracture (HP:0001239) | 2.64940965 |
| 62 | J-shaped sella turcica (HP:0002680) | 2.60903796 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.60317942 |
| 64 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.56925688 |
| 65 | Thrombocytosis (HP:0001894) | 2.51879638 |
| 66 | Neuroendocrine neoplasm (HP:0100634) | 2.49922416 |
| 67 | Slow saccadic eye movements (HP:0000514) | 2.47665317 |
| 68 | Hypoplastic ischia (HP:0003175) | 2.47275041 |
| 69 | Respiratory difficulties (HP:0002880) | 2.47007966 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.45394215 |
| 71 | Abnormality of the endocardium (HP:0004306) | 2.44811439 |
| 72 | Acne (HP:0001061) | 2.42028368 |
| 73 | Recurrent sinusitis (HP:0011108) | 2.41299877 |
| 74 | Gastrointestinal inflammation (HP:0004386) | 2.40011978 |
| 75 | Progressive inability to walk (HP:0002505) | 2.39864940 |
| 76 | Menstrual irregularities (HP:0000858) | 2.38394922 |
| 77 | Supranuclear gaze palsy (HP:0000605) | 2.36522607 |
| 78 | Keratitis (HP:0000491) | 2.34930361 |
| 79 | Hepatitis (HP:0012115) | 2.29884760 |
| 80 | Stomach cancer (HP:0012126) | 2.25605719 |
| 81 | Frequent falls (HP:0002359) | 2.25321140 |
| 82 | Sparse scalp hair (HP:0002209) | 2.24724521 |
| 83 | Inability to walk (HP:0002540) | 2.23326732 |
| 84 | Mediastinal lymphadenopathy (HP:0100721) | 2.21642107 |
| 85 | Recurrent skin infections (HP:0001581) | 2.21106280 |
| 86 | Amyotrophic lateral sclerosis (HP:0007354) | 2.20832006 |
| 87 | Abnormality of the pleura (HP:0002103) | 2.18831264 |
| 88 | Abnormality of the labia minora (HP:0012880) | 2.15647672 |
| 89 | Abnormality of lateral ventricle (HP:0030047) | 2.13980177 |
| 90 | Vasculitis (HP:0002633) | 2.13521217 |
| 91 | Cheilitis (HP:0100825) | 2.13005549 |
| 92 | Villous atrophy (HP:0011473) | 2.12707005 |
| 93 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.12707005 |
| 94 | Obstructive lung disease (HP:0006536) | 2.11878249 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 2.11878249 |
| 96 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.07418123 |
| 97 | Reduced antithrombin III activity (HP:0001976) | 2.06432561 |
| 98 | Polyneuropathy (HP:0001271) | 2.06158655 |
| 99 | Trigonocephaly (HP:0000243) | 2.06017830 |
| 100 | Verrucae (HP:0200043) | 2.05099947 |
| 101 | Papilloma (HP:0012740) | 2.05099947 |
| 102 | Glomerulopathy (HP:0100820) | 2.03668178 |
| 103 | Agammaglobulinemia (HP:0004432) | 2.03129533 |
| 104 | Spontaneous hematomas (HP:0007420) | 2.02460894 |
| 105 | Lymphoma (HP:0002665) | 2.00832252 |
| 106 | Chest pain (HP:0100749) | 2.00562565 |
| 107 | Fatigue (HP:0012378) | 2.00284752 |
| 108 | Homocystinuria (HP:0002156) | 1.96365053 |
| 109 | Abnormality of homocysteine metabolism (HP:0010919) | 1.96365053 |
| 110 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.95919345 |
| 111 | Hemoptysis (HP:0002105) | 1.95062063 |
| 112 | Abnormality of the ischium (HP:0003174) | 1.94332873 |
| 113 | Proximal tubulopathy (HP:0000114) | 1.92030571 |
| 114 | Microcytic anemia (HP:0001935) | 1.90209718 |
| 115 | Long toe (HP:0010511) | 1.88708520 |
| 116 | Meningitis (HP:0001287) | 1.86853603 |
| 117 | Congenital stationary night blindness (HP:0007642) | 1.85051984 |
| 118 | Hyperlipoproteinemia (HP:0010980) | 1.84290611 |
| 119 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84147632 |
| 120 | Urinary urgency (HP:0000012) | 1.83794798 |
| 121 | Beaking of vertebral bodies (HP:0004568) | 1.82848826 |
| 122 | Recurrent abscess formation (HP:0002722) | 1.82062870 |
| 123 | Recurrent bacterial skin infections (HP:0005406) | 1.80682581 |
| 124 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.80399897 |
| 125 | Autoimmune thrombocytopenia (HP:0001973) | 1.79910966 |
| 126 | Large for gestational age (HP:0001520) | 1.78862130 |
| 127 | Chronic sinusitis (HP:0011109) | 1.78681261 |
| 128 | Multiple enchondromatosis (HP:0005701) | 1.78379842 |
| 129 | Abnormal auditory evoked potentials (HP:0006958) | 1.78373551 |
| 130 | Alveolar cell carcinoma (HP:0006519) | 1.77879733 |
| 131 | Abnormality of the pericardium (HP:0001697) | 1.76854476 |
| 132 | Skin rash (HP:0000988) | 1.75788324 |
| 133 | Pulmonary infiltrates (HP:0002113) | 1.74871445 |
| 134 | Renal cortical cysts (HP:0000803) | 1.74804832 |
| 135 | Abnormality of the alveolar ridges (HP:0006477) | 1.73566579 |
| 136 | Arthrogryposis multiplex congenita (HP:0002804) | 1.73225363 |
| 137 | Impaired smooth pursuit (HP:0007772) | 1.71491858 |
| 138 | Gastrointestinal stroma tumor (HP:0100723) | 1.71213209 |
| 139 | Exertional dyspnea (HP:0002875) | 1.69492760 |
| 140 | Emphysema (HP:0002097) | 1.69339136 |
| 141 | Prolonged bleeding time (HP:0003010) | 1.69033507 |
| 142 | Neonatal hypoglycemia (HP:0001998) | 1.68760908 |
| 143 | Abnormality of macular pigmentation (HP:0008002) | 1.68023400 |
| 144 | Type II lissencephaly (HP:0007260) | 1.67526386 |
| 145 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.67337877 |
| 146 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.67337877 |
| 147 | Abnormal protein glycosylation (HP:0012346) | 1.67337877 |
| 148 | Abnormal glycosylation (HP:0012345) | 1.67337877 |
| 149 | Epistaxis (HP:0000421) | 1.66359971 |
| 150 | Global brain atrophy (HP:0002283) | 1.66149416 |
| 151 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.65573118 |
| 152 | Severe visual impairment (HP:0001141) | 1.65365752 |
| 153 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.64423517 |
| 154 | Absent epiphyses (HP:0010577) | 1.64423517 |
| 155 | Upper limb muscle weakness (HP:0003484) | 1.63814106 |
| 156 | Increased serum lactate (HP:0002151) | 1.63301331 |
| 157 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.62438468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.01694746 |
| 2 | TXK | 5.00204832 |
| 3 | ZAP70 | 4.20266836 |
| 4 | MAP4K1 | 4.13456246 |
| 5 | MAP3K10 | 3.60759004 |
| 6 | TESK2 | 3.55685600 |
| 7 | KDR | 3.47207481 |
| 8 | VRK2 | 3.22609229 |
| 9 | EIF2AK1 | 3.15711789 |
| 10 | NEK9 | 2.94852303 |
| 11 | IKBKE | 2.82940547 |
| 12 | JAK3 | 2.64121623 |
| 13 | NLK | 2.54047509 |
| 14 | ITK | 2.49872153 |
| 15 | VRK1 | 2.25736469 |
| 16 | NME2 | 2.25012679 |
| 17 | BTK | 2.18316984 |
| 18 | IRAK4 | 2.13533510 |
| 19 | SIK3 | 2.02288082 |
| 20 | LCK | 1.99606100 |
| 21 | TBK1 | 1.99326605 |
| 22 | HCK | 1.98560740 |
| 23 | PDK4 | 1.97776220 |
| 24 | PDK3 | 1.97776220 |
| 25 | STK10 | 1.86967097 |
| 26 | FGFR4 | 1.86262972 |
| 27 | TEC | 1.85623940 |
| 28 | TAOK3 | 1.77680887 |
| 29 | MST4 | 1.77537986 |
| 30 | GRK6 | 1.56993956 |
| 31 | CSK | 1.55681956 |
| 32 | TYK2 | 1.53488244 |
| 33 | TESK1 | 1.49222382 |
| 34 | RPS6KA4 | 1.46822581 |
| 35 | MAP3K14 | 1.38276526 |
| 36 | SMG1 | 1.35697734 |
| 37 | MAP3K12 | 1.24179201 |
| 38 | LRRK2 | 1.23265507 |
| 39 | JAK1 | 1.23153710 |
| 40 | ERN1 | 1.20593433 |
| 41 | SYK | 1.17770927 |
| 42 | CAMKK2 | 1.17533310 |
| 43 | MAP2K6 | 1.14707545 |
| 44 | BCKDK | 1.09560985 |
| 45 | CDK19 | 1.06882981 |
| 46 | MAP3K13 | 1.04884787 |
| 47 | LYN | 1.03611231 |
| 48 | PRKCH | 1.03070504 |
| 49 | PRKCQ | 0.99721920 |
| 50 | RIPK4 | 0.99593237 |
| 51 | PDK2 | 0.96308368 |
| 52 | MAPK11 | 0.92420878 |
| 53 | CAMKK1 | 0.91273180 |
| 54 | ACVR1B | 0.91108123 |
| 55 | ADRBK2 | 0.89281569 |
| 56 | IRAK3 | 0.85903459 |
| 57 | BLK | 0.78418886 |
| 58 | IRAK1 | 0.77360751 |
| 59 | IKBKB | 0.76769074 |
| 60 | MAP3K3 | 0.76649683 |
| 61 | FGFR3 | 0.73745176 |
| 62 | TGFBR1 | 0.72004649 |
| 63 | NEK1 | 0.70339680 |
| 64 | RPS6KB1 | 0.70105964 |
| 65 | FYN | 0.69200165 |
| 66 | MAPKAPK2 | 0.69034248 |
| 67 | LIMK1 | 0.68115679 |
| 68 | TNK2 | 0.67229950 |
| 69 | EEF2K | 0.66500043 |
| 70 | INSR | 0.65675405 |
| 71 | IRAK2 | 0.64998530 |
| 72 | PIK3CG | 0.62824053 |
| 73 | TAOK1 | 0.58991953 |
| 74 | ZAK | 0.57451777 |
| 75 | CHUK | 0.56950142 |
| 76 | DAPK3 | 0.55953448 |
| 77 | JAK2 | 0.48849692 |
| 78 | IGF1R | 0.48126454 |
| 79 | PDGFRB | 0.47691133 |
| 80 | DAPK1 | 0.45227281 |
| 81 | PDK1 | 0.42661442 |
| 82 | SRC | 0.41648086 |
| 83 | MARK2 | 0.41390404 |
| 84 | MAP2K3 | 0.41046984 |
| 85 | PRKACG | 0.40464540 |
| 86 | TLK1 | 0.37557609 |
| 87 | MARK3 | 0.37516239 |
| 88 | FGFR1 | 0.37158745 |
| 89 | NUAK1 | 0.35887429 |
| 90 | FES | 0.35769577 |
| 91 | HIPK2 | 0.35270209 |
| 92 | TYRO3 | 0.34885332 |
| 93 | MAP3K7 | 0.34204637 |
| 94 | PASK | 0.33892241 |
| 95 | EIF2AK3 | 0.33789082 |
| 96 | STK24 | 0.32066290 |
| 97 | MAP3K11 | 0.31641948 |
| 98 | ABL1 | 0.31130024 |
| 99 | CSF1R | 0.30664772 |
| 100 | ROCK2 | 0.30008809 |
| 101 | PLK3 | 0.29247914 |
| 102 | ROCK1 | 0.28448749 |
| 103 | YES1 | 0.27836733 |
| 104 | TTN | 0.27221007 |
| 105 | PIM1 | 0.26779406 |
| 106 | MAPK9 | 0.26527329 |
| 107 | ALK | 0.26096799 |
| 108 | TGFBR2 | 0.25921952 |
| 109 | WNK1 | 0.25912489 |
| 110 | RPS6KA5 | 0.25328223 |
| 111 | PKN2 | 0.23523583 |
| 112 | MAP3K1 | 0.23149122 |
| 113 | MAPK4 | 0.21829315 |
| 114 | TAF1 | 0.21771383 |
| 115 | SIK2 | 0.21673210 |
| 116 | CDK12 | 0.21474425 |
| 117 | EPHB2 | 0.20839044 |
| 118 | KIT | 0.20424949 |
| 119 | CLK1 | 0.20410977 |
| 120 | BMPR1B | 0.19275689 |
| 121 | TRIM28 | 0.18419041 |
| 122 | DMPK | 0.18201066 |
| 123 | SIK1 | 0.18108625 |
| 124 | GRK7 | 0.17058237 |
| 125 | MAPK12 | 0.16910133 |
| 126 | EPHB1 | 0.16621921 |
| 127 | MAPK7 | 0.16177516 |
| 128 | FGR | 0.15992382 |
| 129 | GRK5 | 0.15972739 |
| 130 | RPS6KB2 | 0.15621443 |
| 131 | STK4 | 0.15482469 |
| 132 | NTRK2 | 0.15210559 |
| 133 | TRPM7 | 0.15189352 |
| 134 | TSSK6 | 0.14691661 |
| 135 | EGFR | 0.13865231 |
| 136 | CSNK2A2 | 0.12961641 |
| 137 | EPHA3 | 0.12717211 |
| 138 | PRKCD | 0.12657342 |
| 139 | TRIB3 | 0.12382212 |
| 140 | CDK4 | 0.11852126 |
| 141 | CAMK1 | 0.11606932 |
| 142 | MAPK3 | 0.11415736 |
| 143 | SRPK1 | 0.10764162 |
| 144 | PRKD2 | 0.10628062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.86321903 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.84249071 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 4.68852542 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.79771456 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.06426395 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.84084780 |
| 7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.76189026 |
| 8 | Measles_Homo sapiens_hsa05162 | 2.67780673 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.65512480 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.49702898 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.35234531 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.27358081 |
| 13 | Viral myocarditis_Homo sapiens_hsa05416 | 2.26666940 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.17505456 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99767595 |
| 16 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.94336460 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.77341062 |
| 18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.65718750 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64633254 |
| 20 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.59836185 |
| 21 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.59324509 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.58929349 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.53345869 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51912280 |
| 25 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30977928 |
| 26 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.28954268 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28116309 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.24275079 |
| 29 | HTLV-I infection_Homo sapiens_hsa05166 | 1.20482550 |
| 30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15733378 |
| 31 | Shigellosis_Homo sapiens_hsa05131 | 1.15275468 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.13425212 |
| 33 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.12981876 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.09313328 |
| 35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08289558 |
| 36 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07295706 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.02069363 |
| 38 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.92391484 |
| 39 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92350588 |
| 40 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89505791 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87283669 |
| 42 | Purine metabolism_Homo sapiens_hsa00230 | 0.82068436 |
| 43 | Adherens junction_Homo sapiens_hsa04520 | 0.80868482 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 0.79869034 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.78959046 |
| 46 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78929177 |
| 47 | Mismatch repair_Homo sapiens_hsa03430 | 0.77667964 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.75347971 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73526618 |
| 50 | Influenza A_Homo sapiens_hsa05164 | 0.72690055 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.71803189 |
| 52 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71483421 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70380936 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.68504967 |
| 55 | Ribosome_Homo sapiens_hsa03010 | 0.67733349 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.67442389 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.66828131 |
| 58 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.66351169 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64423108 |
| 60 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.64106328 |
| 61 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63265629 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.62763996 |
| 63 | Asthma_Homo sapiens_hsa05310 | 0.61841526 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61577881 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.61320048 |
| 66 | Base excision repair_Homo sapiens_hsa03410 | 0.61167201 |
| 67 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.60354930 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59657508 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.59591099 |
| 70 | RNA polymerase_Homo sapiens_hsa03020 | 0.58654234 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.58614568 |
| 72 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54846432 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53189064 |
| 74 | DNA replication_Homo sapiens_hsa03030 | 0.52112935 |
| 75 | Spliceosome_Homo sapiens_hsa03040 | 0.52065727 |
| 76 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.50455747 |
| 77 | Hepatitis B_Homo sapiens_hsa05161 | 0.49696967 |
| 78 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.47752554 |
| 79 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47450937 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.47296111 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.46866165 |
| 82 | Phototransduction_Homo sapiens_hsa04744 | 0.46650582 |
| 83 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46264927 |
| 84 | Apoptosis_Homo sapiens_hsa04210 | 0.45345944 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44547245 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.44535718 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.43429241 |
| 88 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43101694 |
| 89 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43047771 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.42902293 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42763720 |
| 92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41909964 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.41857320 |
| 94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.41630355 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.41291079 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.40731992 |
| 97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.39538146 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.37238475 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | 0.36673626 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.34601309 |
| 101 | RNA degradation_Homo sapiens_hsa03018 | 0.34593863 |
| 102 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.32520812 |
| 103 | Pertussis_Homo sapiens_hsa05133 | 0.31892496 |
| 104 | Homologous recombination_Homo sapiens_hsa03440 | 0.31571050 |
| 105 | Tuberculosis_Homo sapiens_hsa05152 | 0.28744093 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27697876 |
| 107 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27334743 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.27047404 |
| 109 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.26726476 |
| 110 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.26572158 |
| 111 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.25917020 |
| 112 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25108787 |
| 113 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25021726 |
| 114 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.24957454 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.24775120 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22750975 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.20761800 |
| 118 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20368164 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.19769682 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.19464411 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.19063199 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.18695852 |
| 123 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.18573090 |
| 124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.18430876 |
| 125 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.17578278 |
| 126 | Phagosome_Homo sapiens_hsa04145 | 0.16174886 |
| 127 | Lysine degradation_Homo sapiens_hsa00310 | 0.15734568 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.15706861 |
| 129 | RNA transport_Homo sapiens_hsa03013 | 0.15529576 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.14836841 |
| 131 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.13354577 |
| 132 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.13106998 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.12039880 |
| 134 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11832873 |
| 135 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.10711851 |
| 136 | Proteasome_Homo sapiens_hsa03050 | 0.10620063 |
| 137 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.09321656 |

